<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03086057</url>
  </required_header>
  <id_info>
    <org_study_id>1R34MH110369-01</org_study_id>
    <nct_id>NCT03086057</nct_id>
  </id_info>
  <brief_title>Optimizing PrEP Uptake &amp; Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design</brief_title>
  <official_title>Optimizing Pre-exposure Prophylaxis (PrEP) Uptake &amp; Adherence Among MSW Using a 2-stage Randomization Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;PrEPare for Work&quot; is a two-stage randomized controlled pilot trial which utilizes a&#xD;
      behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis&#xD;
      (PrEP) in Male Sex Workers (MSW).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;PrEPare for Work&quot; package includes two behavioral intervention components:&#xD;
&#xD;
        1. Strengths-based case management for PrEP initiation, and&#xD;
&#xD;
        2. Counseling and problem-solving PrEP adherence intervention that addresses individualized&#xD;
           barriers to optimal use.&#xD;
&#xD;
      Stage 1: MSW will be equally randomized to receive either the strengths-based case management&#xD;
      or standard of care referral to PrEP clinic.&#xD;
&#xD;
      Stage 2: Those from stage 1 who initiate PrEP , regardless of stage 1 randomization&#xD;
      condition, will then be equally randomized to either the &quot;PrEPare for Work&quot; adherence&#xD;
      intervention or standard of care comparison condition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">December 15, 2019</completion_date>
  <primary_completion_date type="Actual">December 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In Stage 1, individuals will be randomized (1:1) to receive the experimental PrEP navigation or standard of care. Among those who uptake PrEP in Stage 1, we will randomize those participants in Stage 2 (1:1) to receive the experimental adherence counseling or standard of care.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Verified Attendance at Initial Appointment at PrEP Clinic</measure>
    <time_frame>2-month post Stage 1 randomization</time_frame>
    <description>Number of participants with attendance at initial appointment at PrEP Clinic verified using medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Initiated PrEP</measure>
    <time_frame>2-month post Stage 1 randomization</time_frame>
    <description>Initial prescription from provider filled and shown to study staff</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Optimal PrEP Adherence</measure>
    <time_frame>6-months post Stage 2 randomization</time_frame>
    <description>Self-reporting missing 0 PrEP pills in the past week</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Prevention</condition>
  <arm_group>
    <arm_group_label>Strength Based Case Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PrEP adherence training and counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care:Stage 1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care: Stage 2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PrEPare for Work: Strength Based Case Management (Stage 1)</intervention_name>
    <description>Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
    <arm_group_label>Strength Based Case Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PrEPare for Work: Adherence Training and Counseling (Stage 2)</intervention_name>
    <description>Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
    <arm_group_label>PrEP adherence training and counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Biological male at birth and current male gender identity&#xD;
&#xD;
          -  Exchanged sex for money or drugs with another man in the past 3 months&#xD;
&#xD;
          -  Report behavioral risk for HIV infection, consistent with Centers for Disease Control&#xD;
             and Prevention guidelines for prescribing PrEP: condomless anal intercourse with at&#xD;
             least one HIV-infected or unknown serostatus partner in the past three months&#xD;
&#xD;
          -  HIV uninfected by antibody test* Stage 2&#xD;
&#xD;
          -  Able to understand and speak English (for consent and counseling)&#xD;
&#xD;
          -  Mental competency to provide voluntary informed consent&#xD;
&#xD;
          -  Lives in the New England area&#xD;
&#xD;
          -  Willing to initiate PrEP&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to provide informed consent, including as a result of severe mental illness&#xD;
             requiring immediate treatment or mental illness limiting the ability to participate&#xD;
&#xD;
          -  HIV Positive at baseline&#xD;
&#xD;
          -  Infected with Hepatitis B or diagnosed with renal insufficiency (glomerular filtration&#xD;
             rate &lt; 50) *Stage 2&#xD;
&#xD;
          -  History of or current medical conditions that would preclude taking Truvada for PrEP&#xD;
             *Stage 2&#xD;
&#xD;
          -  Currently taking Truvada for PrEP&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Biological male at birth and current male gender identity</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Mimiaga, ScD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University, School of Public Health, Center for Health Equity Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University School of Public Health</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <results_first_submitted>February 3, 2021</results_first_submitted>
  <results_first_submitted_qc>February 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 15, 2021</results_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Matthew Mimiaga</investigator_full_name>
    <investigator_title>ScD, MPH</investigator_title>
  </responsible_party>
  <keyword>PrEP</keyword>
  <keyword>Prevention</keyword>
  <keyword>Male Sex Workers (MSW)</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>It is anticipated that this data will be presented annually on data collected after the second year when sufficient baseline data is collected. It is anticipated that most of the papers and data-based projects/presentations will happen in year 3, when all of the baseline data is collected, and the 3 month outcome has occurred for all participants. Sharing of the findings will involve a primary paper describing the study outcome and a paper that describes the intervention, as well as submitting to lead workshops on the intervention approach at relevant national meetings and conferences. Raw data for additional analysis will be available to outside individuals through contacting the MPIs. Information regarding the availability of data for analysis will be listed on the MPIs' web pages. Contact information for the MPIs will be listed in all manuscripts and publications as another means to access data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03086057/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03086057/Prot_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 15, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03086057/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One participant was partially enrolled and never completed enrollment. Only participants who completed Stage 1 AND who initiated PrEP were included in Stage 2.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Strength Based Case Management</title>
          <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.&#xD;
PrEPare for Work: Strength Based Case Management (Stage 1): Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care:Stage 1</title>
          <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
        </group>
        <group group_id="P3">
          <title>PrEP Adherence Training and Counseling</title>
          <description>Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.&#xD;
PrEPare for Work: Adherence Training and Counseling (Stage 2): Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
        </group>
        <group group_id="P4">
          <title>Standard of Care: Stage 2</title>
          <description>Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Stage 1: PrEP Uptake</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="55"/>
                <participants group_id="P3" count="0">This intervention was not provided until Stage 2</participants>
                <participants group_id="P4" count="0">This intervention was not provided until Stage 2</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Incarcerated</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Stage 2: PrEP Adherence</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">This was only provided in Stage 1</participants>
                <participants group_id="P2" count="0">This was only provided in Stage 1</participants>
                <participants group_id="P3" count="17">Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.</participants>
                <participants group_id="P4" count="18">Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Incarcerated</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This was a two-stage sequential randomization design. Therefore, all of those in the Stage 2 arms (PrEP adherence training and counseling and Standard of Care) are already counted in Stage 1 arms.</population>
      <group_list>
        <group group_id="B1">
          <title>Strength Based Case Management</title>
          <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.&#xD;
PrEPare for Work: Strength Based Case Management (Stage 1): Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care:Stage 1</title>
          <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
        </group>
        <group group_id="B3">
          <title>PrEP Adherence Training and Counseling</title>
          <description>Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.&#xD;
PrEPare for Work: Adherence Training and Counseling (Stage 2): Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
        </group>
        <group group_id="B4">
          <title>Standard of Care: Stage 2</title>
          <description>Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
            <count group_id="B2" value="55"/>
            <count group_id="B3" value="0"/>
            <count group_id="B4" value="0"/>
            <count group_id="B5" value="110"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.6" spread="7.8"/>
                    <measurement group_id="B2" value="34.6" spread="9.2"/>
                    <measurement group_id="B5" value="34.2" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B5" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White, non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B5" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black, non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B5" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B5" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B5" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PrEP Use Self-Efficacy</title>
          <description>Summary measure - range 0-10, with higher scores indicating higher self-efficacy for using PrEP</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.1" spread="3.2"/>
                    <measurement group_id="B2" value="7.7" spread="2.1"/>
                    <measurement group_id="B5" value="7.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Verified Attendance at Initial Appointment at PrEP Clinic</title>
        <description>Number of participants with attendance at initial appointment at PrEP Clinic verified using medical records</description>
        <time_frame>2-month post Stage 1 randomization</time_frame>
        <population>Per study design, linkage to PrEP care was only assessed in Stage 1; Additionally, because this was based on medical records we could include anyone that was not withdrawn or incarcerated or had died (n=5 in each arm).</population>
        <group_list>
          <group group_id="O1">
            <title>Strength Based Case Management</title>
            <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.&#xD;
PrEPare for Work: Strength Based Case Management (Stage 1): Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care:Stage 1</title>
            <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Verified Attendance at Initial Appointment at PrEP Clinic</title>
          <description>Number of participants with attendance at initial appointment at PrEP Clinic verified using medical records</description>
          <population>Per study design, linkage to PrEP care was only assessed in Stage 1; Additionally, because this was based on medical records we could include anyone that was not withdrawn or incarcerated or had died (n=5 in each arm).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Initiated PrEP</title>
        <description>Initial prescription from provider filled and shown to study staff</description>
        <time_frame>2-month post Stage 1 randomization</time_frame>
        <population>Per study design, PrEP initiation was only assessed in Stage 1; Additionally, because this required proof of prescription, we excluded those who were loss to follow up for Stage 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Strength Based Case Management</title>
            <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.&#xD;
PrEPare for Work: Strength Based Case Management (Stage 1): Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care:Stage 1</title>
            <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Initiated PrEP</title>
          <description>Initial prescription from provider filled and shown to study staff</description>
          <population>Per study design, PrEP initiation was only assessed in Stage 1; Additionally, because this required proof of prescription, we excluded those who were loss to follow up for Stage 1.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Optimal PrEP Adherence</title>
        <description>Self-reporting missing 0 PrEP pills in the past week</description>
        <time_frame>6-months post Stage 2 randomization</time_frame>
        <population>Per study design, PrEP adherence was only assessed in Stage 2 (and among Stage 2 participants); Additionally, because this was based on self-report, PrEP adherence was only assessed among those with follow up data.</population>
        <group_list>
          <group group_id="O1">
            <title>PrEP Adherence Training and Counseling</title>
            <description>Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.&#xD;
PrEPare for Work: Adherence Training and Counseling (Stage 2): Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care: Stage 2</title>
            <description>Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Optimal PrEP Adherence</title>
          <description>Self-reporting missing 0 PrEP pills in the past week</description>
          <population>Per study design, PrEP adherence was only assessed in Stage 2 (and among Stage 2 participants); Additionally, because this was based on self-report, PrEP adherence was only assessed among those with follow up data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For participants only in Stage 1, adverse event data were collected for approximately 2 months for each participant. For participants subsequently randomized into Stage 2, adverse event data were collected for an additional 6 months for each participant.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Strength Based Case Management</title>
          <description>Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.&#xD;
PrEPare for Work: Strength Based Case Management (Stage 1): Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care:Stage 1</title>
          <description>Stage 1: Referral to The Miriam Hospital PrEP Clinic.</description>
        </group>
        <group group_id="E3">
          <title>PrEP Adherence Training and Counseling</title>
          <description>Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.&#xD;
PrEPare for Work: Adherence Training and Counseling (Stage 2): Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.</description>
        </group>
        <group group_id="E4">
          <title>Standard of Care: Stage 2</title>
          <description>Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Potential Disclosure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Homicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Police involvement</sub_title>
                <description>Using study phone to call police (but then hang up)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Due to COVID, we are delayed in receiving the results of our biomarkers (specifically, hair analysis for PrEP adherence).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Katie Biello</name_or_title>
      <organization>Brown University</organization>
      <phone>401-863-3082</phone>
      <email>katie_biello@brown.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

